Compound Profile
Acemannan
Acetylated mannose rich polysaccharide from aloe gel commonly associated with immunomodulatory and wound healing activity.
Last reviewed: •1 human studies cited
C PreliminaryMonograph visual
Acemannan
Generated profile category visual
Where to go next — guides & comparisons
Continue reading
- If you want to browse more compounds → All compounds
Quick Stats
Evidence level
Limited evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Interaction risk
Best for
NF κB
Found In
Botanicals that contain Acemannan, with full herb profiles.
Safety & Cautions
Safety evidence
one controlled human trial in a narrow clinical population
Who should avoid this?
No specific evidence-backed contraindication is documented for this profile. This is not the same as established safety.
In a 48-week trial in 63 men with advanced HIV disease, oral acemannan had no significant adverse-event difference from placebo and no significant pharmacokinetic interaction with zidovudine; other populations, pregnancy, breastfeeding, organ impairment, and other medications remain insufficiently studied.
Talk to a healthcare professional if: you use relevant medications, you are pregnant or breastfeeding.
Evidence Summary
C PreliminaryEvidence lens
Early signal that needs stronger human replication before practical claims.
PreliminaryLimited evidence
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Immune Signaling Modulation · NF KB Modulation
Research maturity: Preliminary or mixed — main contexts: NF κB
Safety boundary: Safety note available — Review medications, pregnancy status, chronic conditions, and clinician guidance before use.
This profile cites 1 human study.
Evidence Strength
Confidence estimate based on the design quality and consistency of published clinical trials.
Acemannan has a limited evidence evidence rating.
General wellnessGeneral wellness
Citation density
1.0
Sources
1
Effects
1
Research recency
Mixed recency
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
A
Strong
Multiple RCTs, consistent direction, adequate effect size
B
Moderate
Some RCTs or consistent observational data in humans
C
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
D
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (1)Cited studies informing this profile. RCTs and reviews shown first.
| Study | Type | Sample | Source |
|---|---|---|---|
Requires manual source normalization to PMID, DOI, PMC, or authoritative URL. | — | — | — |
How Acemannan Works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Acemannan Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & Biological Pathways▼
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Inflammatory Signaling ModulationImmune Signaling ModulationNF KB ModulationInflammatory
Condition guides
Continue exploring
Related research paths
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Review available sources for Acemannan
Independent database mapping — evaluated separately from safety and efficacy scores.
Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.
Related alternatives
Herbs for similar conditions
Tradeoffs
Free safety checklist
Get the Acemannan evidence notes
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Compound profile context
How to interpret Acemannan
Acemannan dosage by use case, onset and duration, safety limits, and interactions for nf κb, graded against research. Limited Human Evidence research evidence. Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.
When reviewing Acemannan, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.
For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.